tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MLTX Stock Latest News

MoonLake price target lowered to $26 from $30 at H.C. Wainwright
The FlyMoonLake price target lowered to $26 from $30 at H.C. Wainwright
6d ago
MLTX
MoonLake Immunotherapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
MoonLake Immunotherapeutics Reports Q3 2025 Financial Results
20d ago
MLTX
MoonLake Immunotherapeutics price target raised to $30 from $25 at Oppenheimer
PremiumThe Fly
MoonLake Immunotherapeutics price target raised to $30 from $25 at Oppenheimer
20d ago
MLTX
MoonLake Immunotherapeutics price target raised to $8 from $7 at Goldman Sachs
PremiumThe Fly
MoonLake Immunotherapeutics price target raised to $8 from $7 at Goldman Sachs
20d ago
MLTX
MoonLake Immunotherapeutics Announces $75M Share Offering
PremiumCompany Announcements
MoonLake Immunotherapeutics Announces $75M Share Offering
21d ago
8K
MLTX
MoonLake Immunotherapeutics’ SLK Program: Buy Rating Backed by Promising Trial Results and Upcoming Catalysts
PremiumRatingsMoonLake Immunotherapeutics’ SLK Program: Buy Rating Backed by Promising Trial Results and Upcoming Catalysts
21d ago
MLTX
MoonLake Immunotherapeutics: Strong Financials and Promising Clinical Developments Drive Buy Rating
Premium
Ratings
MoonLake Immunotherapeutics: Strong Financials and Promising Clinical Developments Drive Buy Rating
21d ago
MLTX
MoonLake Immunotherapeutics: Promising Clinical Trials and Strategic Regulatory Advances Boost Confidence in Sonelokimab
Premium
Ratings
MoonLake Immunotherapeutics: Promising Clinical Trials and Strategic Regulatory Advances Boost Confidence in Sonelokimab
21d ago
MLTX
MoonLake prices 7.14M shares at $10.50 in underwritten offering
PremiumThe Fly
MoonLake prices 7.14M shares at $10.50 in underwritten offering
21d ago
MLTX
MoonLake Reports Promising Phase 2 Trial Results
PremiumCompany Announcements
MoonLake Reports Promising Phase 2 Trial Results
21d ago
8K
MLTX
MoonLake Immunotherapeutics releases data from clinical trials of Nanobody SLK
PremiumThe Fly
MoonLake Immunotherapeutics releases data from clinical trials of Nanobody SLK
22d ago
MLTX
MoonLake Immunotherapeutics reports Q3 EPS ($1.10), consensus (92c)
PremiumThe Fly
MoonLake Immunotherapeutics reports Q3 EPS ($1.10), consensus (92c)
22d ago
MLTX
MoonLake Immunotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe FlyMoonLake Immunotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
24d ago
MLTX
Buy/Sell: Wall Street’s top 10 stock calls this week
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
26d ago
HOG
OGN
MoonLake Immunotherapeutics downgraded to Sell from Neutral at Citi
Premium
The Fly
MoonLake Immunotherapeutics downgraded to Sell from Neutral at Citi
29d ago
MLTX
Moonlake Immunotherapeutics Advances Psoriatic Arthritis Treatment with Sonelokimab Study
PremiumCompany Announcements
Moonlake Immunotherapeutics Advances Psoriatic Arthritis Treatment with Sonelokimab Study
1M ago
MLTX
MoonLake Immunotherapeutics Advances with Promising Sonelokimab Study in Adolescents
PremiumCompany Announcements
MoonLake Immunotherapeutics Advances with Promising Sonelokimab Study in Adolescents
1M ago
MLTX
Moonlake Immunotherapeutics Advances in Hidradenitis Suppurativa Treatment with Sonelokimab Study
PremiumCompany Announcements
Moonlake Immunotherapeutics Advances in Hidradenitis Suppurativa Treatment with Sonelokimab Study
1M ago
MLTX
MoonLake’s Promising Phase 3 Study on Sonelokimab for Psoriatic Arthritis
PremiumCompany Announcements
MoonLake’s Promising Phase 3 Study on Sonelokimab for Psoriatic Arthritis
1M ago
MLTX
MoonLake Faces Legal Storm Over SLK Drug Claims
PremiumClass ActionMoonLake Faces Legal Storm Over SLK Drug Claims
1M ago
MLTX
MoonLake Immunotherapeutics price target lowered to $25 from $104 at Oppenheimer
Premium
The Fly
MoonLake Immunotherapeutics price target lowered to $25 from $104 at Oppenheimer
2M ago
MLTX
Unusually active option classes on open October 3rd
Premium
The Fly
Unusually active option classes on open October 3rd
2M ago
CAN
EYE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >